Recent Updates
Recently added Catalysts
WST Positive Sentiment Score: 70/100

West to Participate in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...

Key Takeaway: West Pharmaceutical Services, Inc. (NYSE: WST) announced its participation in upcoming investor conferences, showcasing its commitment to engaging with investors. The company is recognized as a global leader in injectable drug administration solutions. With a strong financial performance, generating $2.95 billion in net sales for fiscal year 2023, West is well-positioned within its industry.

Market Sentiment Analysis

POSITIVE FACTORS

  • West Pharmaceutical Services will present at multiple investor conferences, indicating active engagement with the investment community.
  • The company is a leader in innovative solutions for injectable drug administration, highlighting its market position.
  • With significant net sales of $2.95 billion in fiscal year 2023, West demonstrates financial strength.

Full Press Release Details

EXTON, Pa. , Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences:
A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com . Replay of the webcasts will be available for approximately 90 days after the events.
About West West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in Exton, Pennsylvania , West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com .
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
SOURCE West Pharmaceutical Services, Inc.

21 %

Frequently Asked Questions

What does West Pharmaceutical Services specialize in?

West Pharmaceutical Services specializes in innovative injectable drug administration solutions.

Where is West Pharmaceutical Services headquartered?

West Pharmaceutical Services is headquartered in Exton, Pennsylvania.

How much did West generate in net sales for fiscal year 2023?

In fiscal year 2023, West generated $2.95 billion in net sales.

Where can I access West's conference webcasts?

West's conference webcasts can be accessed in the 'Investors' section of their website.

How many components does West deliver each year?

West delivers approximately 43 billion components and devices each year.

Last updated: Oct 29, 2024